{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:40:34Z","timestamp":1778773234885,"version":"3.51.4"},"reference-count":54,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background. In COVID-19 patients, low serum vitamin D (VD) levels have been associated with severe acute respiratory failure and poor prognosis. In regular hemodialysis (HD) patients, there is VD deficiency and markedly reduced calcitriol levels, which may predispose them to worse outcomes of COVID-19 infection. Some hemodialysis patients receive treatment with drugs for secondary hyperparathyroidism, which have well known pleiotropic effects beyond mineral metabolism. The aim of this study was to evaluate the impact of VD status and the administration of active vitamin D medications, used to treat secondary hyperparathyroidism, on survival in a cohort of COVID-19 positive HD patients. Methods. A cross-sectional retrospective observational study was conducted from 12 March to 21 May 2020 in 288 HD patients with positive PCR for SARS-CoV2. Patients were from 52 different centers in Spain. Results. The percent of HD patients with COVID-19 was 6.1% (288 out of 4743). Mortality rate was 28.4% (81\/285). Three patients were lost to follow-up. Serum 25(OH)D (calcidiol) level was 17.1 [10.6\u201327.5] ng\/mL and was not significantly associated to mortality (OR 0.99 (0.97\u20131.01), p = 0.4). Patients receiving active vitamin D medications (16\/94 (17%) vs. 65\/191(34%), p = 0.003), including calcimimetics (4\/49 (8.2%) vs. 77\/236 (32.6%), p = 0.001), paricalcitol or calcimimetics (19\/117 (16.2%) vs. 62\/168 (36.9%); p &lt; 0.001), and also those on both paricalcitol and calcimimetics, to treat secondary hyperparathyroidism (SHPTH) (1\/26 (3.8%) vs. 80\/259 (30.9%), p &lt; 0.001) showed a lower mortality rate than patients receiving no treatment with either drug. Multivariate Cox regression analysis confirmed this increased survival. Conclusions. Our findings suggest that the use of paricalcitol, calcimimetics or the combination of both, seem to be associated with the improvement of survival in HD patients with COVID-19. No correlation was found between serum VD levels and prognosis or outcomes in HD patients with COVID-19. Prospective studies and clinical trials are needed to support these findings.<\/jats:p>","DOI":"10.3390\/nu13082559","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T22:22:46Z","timestamp":1627338166000},"page":"2559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics"],"prefix":"10.3390","volume":"13","author":[{"given":"Mar\u00eda Dolores","family":"Arenas Jimenez","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"},{"name":"Fundaci\u00f3n Renal I\u00f1igo Alvarez de Toledo, 28003 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0701-3969","authenticated-orcid":false,"given":"Emilio","family":"Gonz\u00e1lez-Parra","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Jimenez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-7965","authenticated-orcid":false,"given":"Marta","family":"Riera","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Rinc\u00f3n Bello","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Direcci\u00f3n M\u00e9dica FMC, 28760 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"L\u00f3pez-Herrad\u00f3n","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Direcci\u00f3n M\u00e9dica FMC, 28760 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Higini","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Hurtado","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Direcci\u00f3n M\u00e9dica FMC, 28760 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Collado","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ribera","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Direcci\u00f3n M\u00e9dica FMC, 28760 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Dapena","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Consorci Sanitari Alt Penedes Garraf, 08800 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Torregrosa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Hospital Clinic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4559-9083","authenticated-orcid":false,"given":"Jos\u00e9-Jes\u00fas","family":"Broseta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Consorci Sanitari Alt Penedes Garraf, 08800 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Soto Monta\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Hospital Clinic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5015-7474","authenticated-orcid":false,"given":"Juan F.","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Research Division and Department of Nephrology, Hospital Nuestra Se\u00f1ora de la Candelaria, 38010 Santa Cruz de Tenerife, Spain"},{"name":"Instituto de Tecnolog\u00edas Biom\u00e9dicas, Universidad de La Laguna, 38010 Tenerife, Spain"},{"name":"Red de Investigaci\u00f3n Renal (REDINREN\u2013RD16\/0009\/0022), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ramos","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Direcci\u00f3n M\u00e9dica FMC, 28760 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Can Ruti, 08916 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Nogu\u00e9s-Solan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital del Mar, Institut Mar for Medical Research, CIBERFES, 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1852-2259","authenticated-orcid":false,"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana S.","family":"Dusso","sequence":"additional","affiliation":[{"name":"Bone and Mineral Research Unit, Instituto de Investigaciones Sanitarias del Principado de Asturias, 33011 Oviedo, Spain"},{"name":"Department of Internal Medicine, Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital del Mar, IMIM Hospital del Mar Medical Research Institute, RD16\/0009\/0013 (ISCIII FEDER REDinREN), 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"ref_2","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Arenas, M.D., Crespo, M., P\u00e9rez-S\u00e1ez, M.J., Collado, S., Redondo-Pach\u00f3n, D., Llin\u00e0s-Mallol, L., Montero, M.M., Villar-Garc\u00eda, J., Arias-Cabrales, C., and Barbosa, F. (2020). Clinical Profiles in Renal Patients with COVID-19. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082665"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.kint.2020.04.031","article-title":"COVID-19: Clinical course and outcomes of 36 hemodialysis patients in Spain","volume":"98","author":"Goicoechea","year":"2020","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ckj\/sfaa119","article-title":"The keys to control a COVID-19 outbreak in a haemodialysis unit","volume":"13","author":"Moreso","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-020-01370-x","article-title":"Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19","volume":"44","author":"Carpagnano","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/thoraxjnl-2014-206680","article-title":"Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)","volume":"70","author":"Dancer","year":"2015","journal-title":"Thorax"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"i6583","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau","year":"2017","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/rccm.201909-1867OC","article-title":"Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease","volume":"202","author":"Jolliffe","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/EC-18-0432","article-title":"Vitamin D testing and treatment: A narrative review of current evidence","volume":"8","author":"Pilz","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_18","first-page":"3","article-title":"Recomendaciones de la Sociedad Espa\u00f1ola de Nefrolog\u00eda para el manejo de las alteraciones del metabolismo \u00f3seo-mineral en los pacientes con enfermedad renal cr\u00f3nica (S.E.N.-MM)","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jean, G., Souberbielle, J.C., and Chazot, C. (2017). Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients, 9.","DOI":"10.3390\/nu9040328"},{"key":"ref_21","first-page":"272","article-title":"SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN)","volume":"40","author":"Reina","year":"2020","journal-title":"Nefrologia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.tmaid.2020.101623","article-title":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis","volume":"34","author":"Antezana","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_23","first-page":"295","article-title":"Hyperparathyroidism and dialysis vintage","volume":"54","author":"Chertow","year":"2000","journal-title":"Clin. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000492918","article-title":"The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism","volume":"47","author":"Alfieri","year":"2019","journal-title":"Blood Purif."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/ndt\/gfy016","article-title":"Vitamin D status and mortality risk among patients on dialysis: A systematic review and meta-analysis of observational studies","volume":"33","author":"Zhang","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S2213-8587(17)30357-1","article-title":"Effect of vitamin D supplementation on non-skeletal disorders: A systematic review of meta-analyses and randomised trials","volume":"5","author":"Autier","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Grant, W.B., Lahore, H., McDonnell, S.L., Baggerly, C.A., French, C.B., Aliano, J.L., and Bhattoa, H.P. (2020). Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients, 12.","DOI":"10.20944\/preprints202003.0235.v2"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40520-020-01570-8","article-title":"The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality","volume":"32","author":"Ilie","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jiph.2020.06.021","article-title":"Role of vitamin D in preventing of COVID-19 infection, progression and severity","volume":"13","author":"Ali","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.dsx.2020.04.050","article-title":"Vitamin D concentrations and COVID-19 infection in UK Biobank","volume":"14","author":"Hastie","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1111\/febs.15495","article-title":"Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: An Israeli population-based study","volume":"287","author":"Merzon","year":"2020","journal-title":"FEBS J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e214117","DOI":"10.1001\/jamanetworkopen.2021.4117","article-title":"Association of Vitamin D Levels, Race\/Ethnicity, and Clinical Characteristics With COVID-19 Test Results","volume":"4","author":"Meltzer","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/ndt\/gfr555","article-title":"The effect of vitamin D derivatives on vascular calcification associated with inflammation","volume":"27","author":"Guerrero","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"F534","DOI":"10.1152\/ajprenal.00082.2015","article-title":"Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria","volume":"310","author":"Riera","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats","volume":"32","author":"Grabner","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ndt\/gfx060","article-title":"Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis","volume":"32","author":"Panizo","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105751","DOI":"10.1016\/j.jsbmb.2020.105751","article-title":"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study","volume":"203","author":"Castillo","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1038\/s41467-019-13659-4","article-title":"SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection","volume":"10","author":"Gassen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","article-title":"Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system","volume":"16","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101295","DOI":"10.1016\/j.redox.2019.101295","article-title":"Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system","volume":"26","author":"Cui","year":"2019","journal-title":"Redox Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1099\/vir.0.043919-0","article-title":"Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63","volume":"93","author":"Dijkman","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: A positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ndt\/gfu311","article-title":"The induction of C\/EBP\u03b2 contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease","volume":"30","author":"Arcidiacono","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ndt\/gfaa093","article-title":"ADAM17 inhibition may exert a protective effect on COVID-19","volume":"35","author":"Palau","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ostroverkhova, D.S., Hu, J., Tarasov, V.V., Melnikova, T.I., Porozov, Y.B., and Mutig, K. (2020). Calcium-Sensing Receptor and Regulation of WNK Kinases in the Kidney. Cells, 9.","DOI":"10.3390\/cells9071644"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R1020","DOI":"10.1152\/ajpregu.00238.2010","article-title":"Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo","volume":"299","author":"Atchison","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J. Clin. Investig."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/8\/2559\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:35:12Z","timestamp":1760164512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/8\/2559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["nu13082559"],"URL":"https:\/\/doi.org\/10.3390\/nu13082559","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,26]]}}}